Asociación entre el tiempo de diagnóstico de enfermedad y deterioro cognitivo en pacientes con diabetes Mellitus Tipo 2 del Seguro Social en Lima Metropolitana
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsCajachagua Pucuhuaranga, Ketty Liz
Lanegra Medina, Patricia Del Pilar
Zuloaga Salas, Carmen Rosa
AdvisorsBernabe Ortiz, Antonio
Sanchez Povis, Javier
Luque Cuba, Edith Jacqueline
MetadataShow full item record
Citation1. Pucuhuaranga C, Liz K, Medina L, Pilar P Del, Salas Z, Rosa C. DE ENFERMEDAD Y DETERIORO COGNITIVO EN PACIENTES CON DIABETES MELLITUS TIPO 2 DEL SEGURO SOCIAL EN LIMA METROPOLITANA [Internet]. Universidad Peruana de Ciencias Aplicadas (UPC); 2017. Available from: http://hdl.handle.net/10757/621156
AbstractASSOCIATION BETWEEN THE TIME OF DIAGNOSIS OF ILLNESS AND COGNITIVE IMPAIRMENT IN PATIENTS WITH MELLITUS DIABETES TYPE 2 SOCIAL SECURITY IN LIMA METROPOLITANA ABSTRACT Introduction Type 2 diabetes mellitus is associated with an increased risk of developing cognitive impairment. The aim of this study was to evaluate the association between years of disease diagnosis and cognitive impairment in patients with type 2 diabetes mellitus. Material and methods An analytical cross-sectional study was carried out enrolling patients assisted by the External Consultative Service of Endocrinology in three hospitals of the Social Health Insurance (ESSALUD). Sampling was non-probabilistic with consecutive enrollment. People of both sexes, aged 45 years and older, were included and voluntarily consented to participate in the study. All participants were given the Leganés Cognitive Test (cut-off point ≤22) for cognitive impairment. The exposure of interest was years of diagnosis of diabetes, defined as the self-report of the number of years elapsed from diagnosis to interview and then categorized into groups (≤5, 5-9, 10-14,15-19 and ≥ 20 years). The prevalence ratio (PR) and the 95% confidence intervals (95% CI) were estimated to evaluate the association of the variables of interest. Results A total of 614 participants were evaluated, 54.2% women, and an average age of 66.6 (SD: 4.2). The average disease duration was 14.6 years (SD: 10.4) and 195 (31.8%) had 20 or more years of illness. The prevalence of cognitive impairment was 36.8% (95% CI 33.0% - 40.6%). In the adjusted analysis, those patients with ≥ 20 years of diabetes diagnosis were more likely to have cognitive impairment (RR: 1.59; 95% CI: 1.10-2.29) compared to those with <5 years of disease Conclusion There is a positive association between the time of diagnosis of disease in patients with diabetes and the presence of cognitive impairment.
The following license files are associated with this item: